SlideShare a Scribd company logo
MOVING TOWARDS
VALUE BASED FUNDING
James Downie
CEO
Independent Hospital Pricing Authority
Addendum to the NHRA
• ABF Continues until 2020
• Commonwealth growth capped at 6.5% (price +
volume)
• Reforms to improve efficiency of public hospitals:
‒Healthcare homes
‒Safety and quality considerations
‒Avoidable readmissions
‒Potentially preventable admissions
• New agreement beyond 2020 agreed by 2018
3 www.ihpa.gov.au
Strategic intent of ABF
• Transparency
• Value for money
• Independence
• National comparability
• Technical Efficiency
4
About IHPA
• Independent of all governments
‒Can not be directed on pricing
• Governed by a 9 member board
• 28 member clinical advisory committee
‒Senior medical, nursing and allied health
• 40 staff
‒Data management, statistical, classification, policy
and comms
• Strong consultation and transparency agenda
5
IHPA’s functions
•Set the National Efficient Price
•Classification systems
•Data standards
•Cross border and cost shifting disputes
6
Progress so far
• ABF
‒Admitted Acute
‒Subacute
‒Emergency
‒Non-admitted
• Block Funding
‒Community Mental Health
‒Teaching, training and
research
‒Small rural and remote
hospitals
7
Significant slowdown in costs
8
3664
3809
4023
4312
4400
4548 4549
4588
2006-7 2007-8 2008-9 2009-10 2010-11 2011-12 2012-13 2013-14
Cost per NWAU
Growth Rate: 4.2%
Growth Rate: 1.1%
Benchmarking portal
•ABF generates masses of data
‒ Cost data collection >1,000,000,000
records
•Used properly this data can help improve
the efficiency of hospitals by reducing
variation
•Have to make it accessible at the
hospital level!
10www.ihpa.gov.au
11www.ihpa.gov.au
12www.ihpa.gov.au
Pricing for Safety
and Quality
13 Footer appears here
Premise
• Australian and international costing studies estimate that adverse
events explain between 12.0% and 16.5% of total costs
• ICD-10-AM data is a rich source of safety and quality data,
currently underutilised
• Literature review:
‒ Good evidence that the provision of timely clinical information to
clinicians & managers leads to improvements in patient
outcomes
• Pricing signals:
‒ Provide clear sign that government values safety and quality
‒ Promote discussion of safety and quality systems amongst
clinicians AND managers
14
Approach
• Three areas of focus:
‒Sentinel Events
‒Hospital Acquired Complications
‒Avoidable readmissions
• Data provision to clinicians and managers a critical
component of work
15
Sentinel Events
16
1. Procedures involving the wrong patient or body part resulting in death or major
permanent loss of function
2. Suicide of a patient in an inpatient unit
3. Retained instruments or other material after surgery requiring re-operation or
further surgical procedure
4. Intravascular gas embolism resulting in death or neurological damage
5. Haemolytic blood transfusion reaction resulting from ABO incompatibility
6. Medication error leading to the death of a patient reasonably believed to be due
to incorrect administration of drugs
7. Maternal death associated with pregnancy, birth and the puerperium
8. Infant discharged to the wrong family
Sentinel Events
• From 1 July 2017 no funding for episodes of care with
a sentinel event
• ~100 events per annum (public hospitals)
• Funding impact ~$5 million per annum
17
Hospital Acquired Complications
• Coded data differentiates between conditions present on
admission, and those arising during admission
• Measured using CHADx system:
‒ Too much noise
‒ No measure of preventability
• Hospital Acquired Complications:
‒ Developed by clinicians
• Clear criteria:
‒ Preventability
‒ Patient Impact
‒ Cost Impact
‒ Clinical priority
18
19
Pressure injury Gastrointestinal bleeding
Falls resulting in fracture and intracranial
injury
Medication complications
Healthcare associated infection Delirium
Surgical complications requiring
unplanned return to theatre
Persistent incontinence
Unplanned Intensive Care Unit
admission
Malnutrition
Respiratory complications Cardiac complications
Venous thromboembolism Third and fourth degree perineal
laceration during delivery
Renal failure Birth trauma
Hospital Acquired Complications
HACs add cost
20
HAC
Incremental
cost
All HACs 8.6%
Pressure injury 13.8%
Falls resulting in fracture or other intracranial injury 1.7%
Healthcare associated infection 8.8%
Surgical complications requiring unplanned return to theatre 10.9%
Unplanned intensive care unit admission
Respiratory complications 15.9%
Venous thromboembolism 12.4%
Renal failure 21.7%
Gastrointestinal bleeding 10.0%
Medication complications 8.2%
Delirium 9.8%
Persistent incontinence 2.3%
Malnutrition 7.4%
Cardiac complications 11.3%
Perineal laceration 23.2%
Neonatal birth trauma 10.8%
Rates vary
21
Principle referral hospitals
22
0
2
4
6
8
10
12
14
frequency
Raw HAC rate per 100 episodes
Age is a driver
23
Risk Adjustment Critical
• Patient risk factors:
‒Age
‒DRG
‒Charlson Complexity Score (predicts the one year
mortality for a patient with a range of specific
comorbidities)
‒ICU admission
‒Emergency admission
• Can calculate risk score for every patient
24
25
26
Preventable Readmissions
• All admissions are currently paid for
• Some evidence of preventable readmissions in system
• Currently no nationally agreed, clinically acceptable list
of readmission causes
• List currently being developed – clinically led, data
driven project
• Possible inclusions:
‒Preventable hospitalisations
‒Readmission for HACs
‒Constipation
27
28 www.ihpa.gov.au
www.ihpa.gov.au
29

More Related Content

What's hot

James Downie - Independent Hospital Pricing Authority
James Downie - Independent Hospital Pricing AuthorityJames Downie - Independent Hospital Pricing Authority
James Downie - Independent Hospital Pricing Authority
Informa Australia
 
What Happens After Your Device is Approved? Collecting Data in the Real World
What Happens After Your Device is Approved? Collecting Data in the Real WorldWhat Happens After Your Device is Approved? Collecting Data in the Real World
What Happens After Your Device is Approved? Collecting Data in the Real World
Medpace
 
DRG
DRGDRG
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
PAREXEL International
 
Health IT Summit in Seattle 2014 – “Think Big, Act Small” with Deborah Dahl, ...
Health IT Summit in Seattle 2014 – “Think Big, Act Small” with Deborah Dahl, ...Health IT Summit in Seattle 2014 – “Think Big, Act Small” with Deborah Dahl, ...
Health IT Summit in Seattle 2014 – “Think Big, Act Small” with Deborah Dahl, ...
Health IT Conference – iHT2
 
Effective Strategies for Successful Global Development
Effective Strategies for Successful Global DevelopmentEffective Strategies for Successful Global Development
Effective Strategies for Successful Global Development
PAREXEL International
 
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
Levi Shapiro
 
What's Next in RWE_Amy Rudolph_Novartis_mHealth Israel
What's Next in RWE_Amy Rudolph_Novartis_mHealth IsraelWhat's Next in RWE_Amy Rudolph_Novartis_mHealth Israel
What's Next in RWE_Amy Rudolph_Novartis_mHealth Israel
Levi Shapiro
 
Generating Evidence to Drive Patient Access
Generating Evidence to Drive Patient AccessGenerating Evidence to Drive Patient Access
Generating Evidence to Drive Patient Access
PAREXEL International
 
Health IT Summit Boston 2014 – Case Study “Beyond MU Stage 2: Maximizing the ...
Health IT Summit Boston 2014 – Case Study “Beyond MU Stage 2: Maximizing the ...Health IT Summit Boston 2014 – Case Study “Beyond MU Stage 2: Maximizing the ...
Health IT Summit Boston 2014 – Case Study “Beyond MU Stage 2: Maximizing the ...
Health IT Conference – iHT2
 
Understanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout CommercializationUnderstanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout Commercialization
PAREXEL International
 
A Joint Approach to Value-based Access for Public Drug Plans: Imran Ali (pCPA)
A Joint Approach to Value-based Access for Public Drug Plans: Imran Ali (pCPA)A Joint Approach to Value-based Access for Public Drug Plans: Imran Ali (pCPA)
A Joint Approach to Value-based Access for Public Drug Plans: Imran Ali (pCPA)
Canadian Organization for Rare Disorders
 
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
Canadian Organization for Rare Disorders
 
Development Considerations Comparing Major Markets Including US, EU, Japan an...
Development Considerations Comparing Major Markets Including US, EU, Japan an...Development Considerations Comparing Major Markets Including US, EU, Japan an...
Development Considerations Comparing Major Markets Including US, EU, Japan an...
PAREXEL International
 
Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)
Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)
Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)
Canadian Organization for Rare Disorders
 
Clinical research training - Deirdre Hyland, RCSI - Dec 7th 2016
Clinical research training - Deirdre Hyland, RCSI - Dec 7th 2016Clinical research training - Deirdre Hyland, RCSI - Dec 7th 2016
Clinical research training - Deirdre Hyland, RCSI - Dec 7th 2016
ipposi
 
Seamless Journey from Population Health to Precision Medicine
Seamless Journey from Population Health to Precision MedicineSeamless Journey from Population Health to Precision Medicine
Seamless Journey from Population Health to Precision Medicine
Orion Health
 
Understanding Regulatory and Payer Requirements Throughout Commercialization
Understanding Regulatory and Payer Requirements Throughout CommercializationUnderstanding Regulatory and Payer Requirements Throughout Commercialization
Understanding Regulatory and Payer Requirements Throughout Commercialization
PAREXEL International
 
Towse us and eu comparison slides
Towse us and eu comparison slidesTowse us and eu comparison slides
Towse us and eu comparison slides
Office of Health Economics
 
Scottish Health Intelligence - creating value for the world
Scottish Health Intelligence - creating value for the worldScottish Health Intelligence - creating value for the world
Scottish Health Intelligence - creating value for the world
3GDR
 

What's hot (20)

James Downie - Independent Hospital Pricing Authority
James Downie - Independent Hospital Pricing AuthorityJames Downie - Independent Hospital Pricing Authority
James Downie - Independent Hospital Pricing Authority
 
What Happens After Your Device is Approved? Collecting Data in the Real World
What Happens After Your Device is Approved? Collecting Data in the Real WorldWhat Happens After Your Device is Approved? Collecting Data in the Real World
What Happens After Your Device is Approved? Collecting Data in the Real World
 
DRG
DRGDRG
DRG
 
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpo...
 
Health IT Summit in Seattle 2014 – “Think Big, Act Small” with Deborah Dahl, ...
Health IT Summit in Seattle 2014 – “Think Big, Act Small” with Deborah Dahl, ...Health IT Summit in Seattle 2014 – “Think Big, Act Small” with Deborah Dahl, ...
Health IT Summit in Seattle 2014 – “Think Big, Act Small” with Deborah Dahl, ...
 
Effective Strategies for Successful Global Development
Effective Strategies for Successful Global DevelopmentEffective Strategies for Successful Global Development
Effective Strategies for Successful Global Development
 
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
Real-World Data – What’s Next? by Michael Seewald, AstraZeneca for mHealth Is...
 
What's Next in RWE_Amy Rudolph_Novartis_mHealth Israel
What's Next in RWE_Amy Rudolph_Novartis_mHealth IsraelWhat's Next in RWE_Amy Rudolph_Novartis_mHealth Israel
What's Next in RWE_Amy Rudolph_Novartis_mHealth Israel
 
Generating Evidence to Drive Patient Access
Generating Evidence to Drive Patient AccessGenerating Evidence to Drive Patient Access
Generating Evidence to Drive Patient Access
 
Health IT Summit Boston 2014 – Case Study “Beyond MU Stage 2: Maximizing the ...
Health IT Summit Boston 2014 – Case Study “Beyond MU Stage 2: Maximizing the ...Health IT Summit Boston 2014 – Case Study “Beyond MU Stage 2: Maximizing the ...
Health IT Summit Boston 2014 – Case Study “Beyond MU Stage 2: Maximizing the ...
 
Understanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout CommercializationUnderstanding Different Stakeholder Requirements Throughout Commercialization
Understanding Different Stakeholder Requirements Throughout Commercialization
 
A Joint Approach to Value-based Access for Public Drug Plans: Imran Ali (pCPA)
A Joint Approach to Value-based Access for Public Drug Plans: Imran Ali (pCPA)A Joint Approach to Value-based Access for Public Drug Plans: Imran Ali (pCPA)
A Joint Approach to Value-based Access for Public Drug Plans: Imran Ali (pCPA)
 
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
Managing Value for Sponsors and Users in Public and Private Drug Plans: Angie...
 
Development Considerations Comparing Major Markets Including US, EU, Japan an...
Development Considerations Comparing Major Markets Including US, EU, Japan an...Development Considerations Comparing Major Markets Including US, EU, Japan an...
Development Considerations Comparing Major Markets Including US, EU, Japan an...
 
Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)
Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)
Ensuring Values-based Assessments for Innovative Therapies: Brent Fraser (CADTH)
 
Clinical research training - Deirdre Hyland, RCSI - Dec 7th 2016
Clinical research training - Deirdre Hyland, RCSI - Dec 7th 2016Clinical research training - Deirdre Hyland, RCSI - Dec 7th 2016
Clinical research training - Deirdre Hyland, RCSI - Dec 7th 2016
 
Seamless Journey from Population Health to Precision Medicine
Seamless Journey from Population Health to Precision MedicineSeamless Journey from Population Health to Precision Medicine
Seamless Journey from Population Health to Precision Medicine
 
Understanding Regulatory and Payer Requirements Throughout Commercialization
Understanding Regulatory and Payer Requirements Throughout CommercializationUnderstanding Regulatory and Payer Requirements Throughout Commercialization
Understanding Regulatory and Payer Requirements Throughout Commercialization
 
Towse us and eu comparison slides
Towse us and eu comparison slidesTowse us and eu comparison slides
Towse us and eu comparison slides
 
Scottish Health Intelligence - creating value for the world
Scottish Health Intelligence - creating value for the worldScottish Health Intelligence - creating value for the world
Scottish Health Intelligence - creating value for the world
 

Similar to Moving towards value based funding

Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology
Dr. Ashish singh parihar
 
NVTC Capital Health Tech Summit: Dr. Shannon Keynote
NVTC Capital Health Tech Summit: Dr. Shannon KeynoteNVTC Capital Health Tech Summit: Dr. Shannon Keynote
NVTC Capital Health Tech Summit: Dr. Shannon Keynote
Alexa Magdalenski
 
Quality Orientation.pptx
Quality Orientation.pptxQuality Orientation.pptx
Quality Orientation.pptx
KimTurner50
 
powerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdfpowerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdf
ssuser9828ab
 
Edifecs: Demonstrating who you are in CJR
Edifecs: Demonstrating who you are in CJREdifecs: Demonstrating who you are in CJR
Edifecs: Demonstrating who you are in CJR
Edifecs Inc
 
Connecting Patients, Providers and Payers John Halamka Keynote
Connecting Patients, Providers and Payers John Halamka KeynoteConnecting Patients, Providers and Payers John Halamka Keynote
Connecting Patients, Providers and Payers John Halamka Keynote
mihinpr
 
Main Presentation UK Diagnostic Summit 2018
Main Presentation UK Diagnostic Summit 2018Main Presentation UK Diagnostic Summit 2018
Main Presentation UK Diagnostic Summit 2018
Walt Whitman
 
Advanced Laboratory Analytics — A Disruptive Solution for Health Systems
Advanced Laboratory Analytics — A Disruptive Solution for Health SystemsAdvanced Laboratory Analytics — A Disruptive Solution for Health Systems
Advanced Laboratory Analytics — A Disruptive Solution for Health Systems
Viewics
 
David Glance gfke 2014
David Glance gfke 2014David Glance gfke 2014
David Glance gfke 2014
innovationoecd
 
Learning from Leadership: how to champion the Hospital Harm Measure and Never...
Learning from Leadership: how to champion the Hospital Harm Measure and Never...Learning from Leadership: how to champion the Hospital Harm Measure and Never...
Learning from Leadership: how to champion the Hospital Harm Measure and Never...
Canadian Patient Safety Institute
 
my m health: Wessex PPA slides
my m health: Wessex PPA slidesmy m health: Wessex PPA slides
my m health: Wessex PPA slides
Health Innovation Wessex
 
iHT² Health IT Summit Denver 2013 - Pamela Peele, PhD, Chief Analytics Offic...
 iHT² Health IT Summit Denver 2013 - Pamela Peele, PhD, Chief Analytics Offic... iHT² Health IT Summit Denver 2013 - Pamela Peele, PhD, Chief Analytics Offic...
iHT² Health IT Summit Denver 2013 - Pamela Peele, PhD, Chief Analytics Offic...
Health IT Conference – iHT2
 
A Seven Step Approach to a Clinically Integrated Network.pdf
A Seven Step Approach to a Clinically Integrated Network.pdfA Seven Step Approach to a Clinically Integrated Network.pdf
A Seven Step Approach to a Clinically Integrated Network.pdf
PatWilson13
 
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdfappendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
htpplqzyafxxsptfln
 
Testing Telehealth Solutions for Post Acute Care
Testing Telehealth Solutions for Post Acute CareTesting Telehealth Solutions for Post Acute Care
Testing Telehealth Solutions for Post Acute Care
VSee
 
APO The Kingdom of Thailand Health System Review (Health in Transition)
APO The Kingdom of Thailand Health System Review (Health in Transition)APO The Kingdom of Thailand Health System Review (Health in Transition)
APO The Kingdom of Thailand Health System Review (Health in Transition)
Asia Pacific Observatory on Health Systems and Policies (APO)
 
HSCIC Data Linkage Stakeholder Forum Nov 2013: The Data Linkage and Extract S...
HSCIC Data Linkage Stakeholder Forum Nov 2013: The Data Linkage and Extract S...HSCIC Data Linkage Stakeholder Forum Nov 2013: The Data Linkage and Extract S...
HSCIC Data Linkage Stakeholder Forum Nov 2013: The Data Linkage and Extract S...
The Health and Social Care Information Centre
 

Similar to Moving towards value based funding (20)

James Downie
James DownieJames Downie
James Downie
 
Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology
 
NVTC Capital Health Tech Summit: Dr. Shannon Keynote
NVTC Capital Health Tech Summit: Dr. Shannon KeynoteNVTC Capital Health Tech Summit: Dr. Shannon Keynote
NVTC Capital Health Tech Summit: Dr. Shannon Keynote
 
Quality Orientation.pptx
Quality Orientation.pptxQuality Orientation.pptx
Quality Orientation.pptx
 
powerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdfpowerpoint-presentation-Multi-verse tecto.pdf
powerpoint-presentation-Multi-verse tecto.pdf
 
Edifecs: Demonstrating who you are in CJR
Edifecs: Demonstrating who you are in CJREdifecs: Demonstrating who you are in CJR
Edifecs: Demonstrating who you are in CJR
 
ppm_information
ppm_informationppm_information
ppm_information
 
Connecting Patients, Providers and Payers John Halamka Keynote
Connecting Patients, Providers and Payers John Halamka KeynoteConnecting Patients, Providers and Payers John Halamka Keynote
Connecting Patients, Providers and Payers John Halamka Keynote
 
Main Presentation UK Diagnostic Summit 2018
Main Presentation UK Diagnostic Summit 2018Main Presentation UK Diagnostic Summit 2018
Main Presentation UK Diagnostic Summit 2018
 
David page cord standards of care 05 03-2015
David page cord standards of  care 05 03-2015David page cord standards of  care 05 03-2015
David page cord standards of care 05 03-2015
 
Advanced Laboratory Analytics — A Disruptive Solution for Health Systems
Advanced Laboratory Analytics — A Disruptive Solution for Health SystemsAdvanced Laboratory Analytics — A Disruptive Solution for Health Systems
Advanced Laboratory Analytics — A Disruptive Solution for Health Systems
 
David Glance gfke 2014
David Glance gfke 2014David Glance gfke 2014
David Glance gfke 2014
 
Learning from Leadership: how to champion the Hospital Harm Measure and Never...
Learning from Leadership: how to champion the Hospital Harm Measure and Never...Learning from Leadership: how to champion the Hospital Harm Measure and Never...
Learning from Leadership: how to champion the Hospital Harm Measure and Never...
 
my m health: Wessex PPA slides
my m health: Wessex PPA slidesmy m health: Wessex PPA slides
my m health: Wessex PPA slides
 
iHT² Health IT Summit Denver 2013 - Pamela Peele, PhD, Chief Analytics Offic...
 iHT² Health IT Summit Denver 2013 - Pamela Peele, PhD, Chief Analytics Offic... iHT² Health IT Summit Denver 2013 - Pamela Peele, PhD, Chief Analytics Offic...
iHT² Health IT Summit Denver 2013 - Pamela Peele, PhD, Chief Analytics Offic...
 
A Seven Step Approach to a Clinically Integrated Network.pdf
A Seven Step Approach to a Clinically Integrated Network.pdfA Seven Step Approach to a Clinically Integrated Network.pdf
A Seven Step Approach to a Clinically Integrated Network.pdf
 
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdfappendix-4--powerpoint-presentation-single-unit-transfusion.pdf
appendix-4--powerpoint-presentation-single-unit-transfusion.pdf
 
Testing Telehealth Solutions for Post Acute Care
Testing Telehealth Solutions for Post Acute CareTesting Telehealth Solutions for Post Acute Care
Testing Telehealth Solutions for Post Acute Care
 
APO The Kingdom of Thailand Health System Review (Health in Transition)
APO The Kingdom of Thailand Health System Review (Health in Transition)APO The Kingdom of Thailand Health System Review (Health in Transition)
APO The Kingdom of Thailand Health System Review (Health in Transition)
 
HSCIC Data Linkage Stakeholder Forum Nov 2013: The Data Linkage and Extract S...
HSCIC Data Linkage Stakeholder Forum Nov 2013: The Data Linkage and Extract S...HSCIC Data Linkage Stakeholder Forum Nov 2013: The Data Linkage and Extract S...
HSCIC Data Linkage Stakeholder Forum Nov 2013: The Data Linkage and Extract S...
 

Recently uploaded

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
aunty1x2
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
Azreen Aj
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
Deepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptxDeepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptx
mahalsuraj389
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
renewlifehypnosis
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Sachin Sharma
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
preciousstephanie75
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
Nguyễn Thị Vân Anh
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
roti bank
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
LAB Sports Therapy
 

Recently uploaded (20)

Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020QA Paediatric dentistry department, Hospital Melaka 2020
QA Paediatric dentistry department, Hospital Melaka 2020
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
Deepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptxDeepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptx
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
Surgery-Mini-OSCE-All-Past-Years-Questions-Modified.
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
 
Roti bank chennai PPT [Autosaved].pptx1
Roti bank  chennai PPT [Autosaved].pptx1Roti bank  chennai PPT [Autosaved].pptx1
Roti bank chennai PPT [Autosaved].pptx1
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
 

Moving towards value based funding

  • 1. MOVING TOWARDS VALUE BASED FUNDING James Downie CEO Independent Hospital Pricing Authority
  • 2.
  • 3. Addendum to the NHRA • ABF Continues until 2020 • Commonwealth growth capped at 6.5% (price + volume) • Reforms to improve efficiency of public hospitals: ‒Healthcare homes ‒Safety and quality considerations ‒Avoidable readmissions ‒Potentially preventable admissions • New agreement beyond 2020 agreed by 2018 3 www.ihpa.gov.au
  • 4. Strategic intent of ABF • Transparency • Value for money • Independence • National comparability • Technical Efficiency 4
  • 5. About IHPA • Independent of all governments ‒Can not be directed on pricing • Governed by a 9 member board • 28 member clinical advisory committee ‒Senior medical, nursing and allied health • 40 staff ‒Data management, statistical, classification, policy and comms • Strong consultation and transparency agenda 5
  • 6. IHPA’s functions •Set the National Efficient Price •Classification systems •Data standards •Cross border and cost shifting disputes 6
  • 7. Progress so far • ABF ‒Admitted Acute ‒Subacute ‒Emergency ‒Non-admitted • Block Funding ‒Community Mental Health ‒Teaching, training and research ‒Small rural and remote hospitals 7
  • 8. Significant slowdown in costs 8 3664 3809 4023 4312 4400 4548 4549 4588 2006-7 2007-8 2008-9 2009-10 2010-11 2011-12 2012-13 2013-14 Cost per NWAU Growth Rate: 4.2% Growth Rate: 1.1%
  • 9. Benchmarking portal •ABF generates masses of data ‒ Cost data collection >1,000,000,000 records •Used properly this data can help improve the efficiency of hospitals by reducing variation •Have to make it accessible at the hospital level!
  • 13. Pricing for Safety and Quality 13 Footer appears here
  • 14. Premise • Australian and international costing studies estimate that adverse events explain between 12.0% and 16.5% of total costs • ICD-10-AM data is a rich source of safety and quality data, currently underutilised • Literature review: ‒ Good evidence that the provision of timely clinical information to clinicians & managers leads to improvements in patient outcomes • Pricing signals: ‒ Provide clear sign that government values safety and quality ‒ Promote discussion of safety and quality systems amongst clinicians AND managers 14
  • 15. Approach • Three areas of focus: ‒Sentinel Events ‒Hospital Acquired Complications ‒Avoidable readmissions • Data provision to clinicians and managers a critical component of work 15
  • 16. Sentinel Events 16 1. Procedures involving the wrong patient or body part resulting in death or major permanent loss of function 2. Suicide of a patient in an inpatient unit 3. Retained instruments or other material after surgery requiring re-operation or further surgical procedure 4. Intravascular gas embolism resulting in death or neurological damage 5. Haemolytic blood transfusion reaction resulting from ABO incompatibility 6. Medication error leading to the death of a patient reasonably believed to be due to incorrect administration of drugs 7. Maternal death associated with pregnancy, birth and the puerperium 8. Infant discharged to the wrong family
  • 17. Sentinel Events • From 1 July 2017 no funding for episodes of care with a sentinel event • ~100 events per annum (public hospitals) • Funding impact ~$5 million per annum 17
  • 18. Hospital Acquired Complications • Coded data differentiates between conditions present on admission, and those arising during admission • Measured using CHADx system: ‒ Too much noise ‒ No measure of preventability • Hospital Acquired Complications: ‒ Developed by clinicians • Clear criteria: ‒ Preventability ‒ Patient Impact ‒ Cost Impact ‒ Clinical priority 18
  • 19. 19 Pressure injury Gastrointestinal bleeding Falls resulting in fracture and intracranial injury Medication complications Healthcare associated infection Delirium Surgical complications requiring unplanned return to theatre Persistent incontinence Unplanned Intensive Care Unit admission Malnutrition Respiratory complications Cardiac complications Venous thromboembolism Third and fourth degree perineal laceration during delivery Renal failure Birth trauma Hospital Acquired Complications
  • 20. HACs add cost 20 HAC Incremental cost All HACs 8.6% Pressure injury 13.8% Falls resulting in fracture or other intracranial injury 1.7% Healthcare associated infection 8.8% Surgical complications requiring unplanned return to theatre 10.9% Unplanned intensive care unit admission Respiratory complications 15.9% Venous thromboembolism 12.4% Renal failure 21.7% Gastrointestinal bleeding 10.0% Medication complications 8.2% Delirium 9.8% Persistent incontinence 2.3% Malnutrition 7.4% Cardiac complications 11.3% Perineal laceration 23.2% Neonatal birth trauma 10.8%
  • 23. Age is a driver 23
  • 24. Risk Adjustment Critical • Patient risk factors: ‒Age ‒DRG ‒Charlson Complexity Score (predicts the one year mortality for a patient with a range of specific comorbidities) ‒ICU admission ‒Emergency admission • Can calculate risk score for every patient 24
  • 25. 25
  • 26. 26
  • 27. Preventable Readmissions • All admissions are currently paid for • Some evidence of preventable readmissions in system • Currently no nationally agreed, clinically acceptable list of readmission causes • List currently being developed – clinically led, data driven project • Possible inclusions: ‒Preventable hospitalisations ‒Readmission for HACs ‒Constipation 27